Intellia Therapeutics Inc. Earnings

Intellia Therapeutics Inc.’s revenue jumped 78.79% since last year same period to $23.02Mn in the Q4 2025. On a quarterly growth basis, Intellia Therapeutics Inc. has generated 67.01% jump in its revenue since last 3-months.

Intellia Therapeutics Inc.’s net profit jumped 25.69% since last year same period to $-95.79Mn in the Q4 2025. On a quarterly growth basis, Intellia Therapeutics Inc. has generated 5.47% jump in its net profits since last 3-months.

Intellia Therapeutics Inc.’s net profit margin jumped 58.44% since last year same period to -416.15% in the Q4 2025. On a quarterly growth basis, Intellia Therapeutics Inc. has generated 43.4% jump in its net profit margins since last 3-months.

Intellia Therapeutics Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.9 - a 5.83% jump from last quarter’s estimates.

Intellia Therapeutics Inc.’s earning per share (EPS) estimates for the current year stand at -0.9.

Intellia Therapeutics Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Intellia Therapeutics Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.